Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Khamashta

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Clinical Immunology and Immunopathology|March 1, 1994
Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitisN Del Papa, G Conforti, D Gambini, et al.
Autoimmunity Reviews|January 15, 2014
Patterns of systemic lupus erythematosus expression in EuropeR Cervera, A Doria, Z Amoura, et al.
Lupus|February 10, 2011
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodiesG Ruiz-Irastorza, M J Cuadrado, I Ruiz-Arruza, et al.
Rheumatology (Oxford, England)|April 9, 2005
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosusD A Isenberg, A Rahman, E Allen, et al.
Journal of Thrombosis and Haemostasis : JTH|July 7, 2018
McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndromeK Legault, H Schunemann, C Hillis, et al.
Annals of the Rheumatic Diseases|May 17, 2007
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including TherapeuticsG Bertsias, J P A Ioannidis, J Boletis, et al.
Annals of the Rheumatic Diseases|April 25, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpointsG K Bertsias, J P A Ioannidis, J Boletis, et al.
Annals of the Rheumatic Diseases|July 27, 2016
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndromeL Andreoli, G K Bertsias, N Agmon-Levin, et al.
Annals of the Rheumatic Diseases|September 14, 2010
An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENAD A Isenberg, E Allen, V Farewell, et al.
Lupus|August 31, 2007
Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohortM B Urowitz, D Gladman, D Ibañez, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Clinical Immunology and Immunopathology|March 1, 1994
Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitisN Del Papa, G Conforti, D Gambini, et al.
Autoimmunity Reviews|January 15, 2014
Patterns of systemic lupus erythematosus expression in EuropeR Cervera, A Doria, Z Amoura, et al.
Lupus|February 10, 2011
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodiesG Ruiz-Irastorza, M J Cuadrado, I Ruiz-Arruza, et al.
Rheumatology (Oxford, England)|April 9, 2005
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosusD A Isenberg, A Rahman, E Allen, et al.
Journal of Thrombosis and Haemostasis : JTH|July 7, 2018
McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndromeK Legault, H Schunemann, C Hillis, et al.
Annals of the Rheumatic Diseases|May 17, 2007
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including TherapeuticsG Bertsias, J P A Ioannidis, J Boletis, et al.
Annals of the Rheumatic Diseases|April 25, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpointsG K Bertsias, J P A Ioannidis, J Boletis, et al.
Annals of the Rheumatic Diseases|July 27, 2016
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndromeL Andreoli, G K Bertsias, N Agmon-Levin, et al.
Annals of the Rheumatic Diseases|September 14, 2010
An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENAD A Isenberg, E Allen, V Farewell, et al.
Lupus|August 31, 2007
Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohortM B Urowitz, D Gladman, D Ibañez, et al.
Pageof 9